Natixis Advisors, L.P. Vertex Pharmaceuticals Inc Transaction History

Natixis Advisors, L.P.

  • $63 Billion
  • Q2 2025

A detailed history of Natixis Advisors, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 540,530 shares of VRTX stock, worth $218 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
540,530
Previous 601,187 10.09%
Holding current value
$218 Million
Previous $291 Million 17.44%
% of portfolio
0.38%
Previous 0.54%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$421.16 - $509.5 $25.5 Million - $30.9 Million
-60,657 Reduced 10.09%
540,530 $241 Million
Q1 2025

May 08, 2025
BUY
$402.49 - $513.76 $17.5 Million - $22.4 Million
43,543 Added 7.81%
601,187 $291 Million
Q4 2024

Feb 10, 2025
BUY
$396.64 - $516.74 $38 Million - $49.5 Million
95,758 Added 20.73%
557,644 $225 Million
Q3 2024

Nov 06, 2024
BUY
$460.0 - $505.78 $11.6 Million - $12.8 Million
25,301 Added 5.8%
461,886 $215 Million
Q2 2024

Aug 01, 2024
BUY
$392.81 - $485.53 $41.1 Million - $50.7 Million
104,522 Added 31.48%
436,585 $205 Million
Q1 2024

Apr 25, 2024
BUY
$407.69 - $446.08 $5.13 Million - $5.61 Million
12,587 Added 3.94%
332,063 $139 Million
Q4 2023

Feb 06, 2024
BUY
$343.0 - $410.68 $91,238 - $109,240
266 Added 0.08%
319,476 $130 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $52.1 Million - $55.8 Million
-153,998 Reduced 32.54%
319,210 $111 Million
Q2 2023

Aug 15, 2023
BUY
$314.42 - $351.91 $3.21 Million - $3.6 Million
10,220 Added 2.21%
473,208 $167 Million
Q1 2023

May 11, 2023
SELL
$283.23 - $323.1 $1.23 Million - $1.4 Million
-4,344 Reduced 0.93%
462,988 $146 Million
Q4 2022

Jan 27, 2023
SELL
$285.76 - $321.48 $11.7 Million - $13.2 Million
-41,088 Reduced 8.08%
467,332 $135 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $26.2 Million - $29.3 Million
-95,775 Reduced 15.85%
508,420 $147 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $15.6 Million - $19.4 Million
-66,323 Reduced 9.89%
604,195 $170 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $601,376 - $708,794
2,716 Added 0.41%
670,518 $175 Million
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $9.04 Million - $11.4 Million
51,094 Added 8.28%
667,802 $147 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $74 Million - $82.8 Million
407,937 Added 195.4%
616,708 $112 Million
Q2 2021

Aug 12, 2021
BUY
$187.49 - $221.1 $7.06 Million - $8.33 Million
37,665 Added 22.01%
208,771 $42.1 Million
Q1 2021

May 05, 2021
BUY
$207.02 - $241.31 $6.34 Million - $7.39 Million
30,638 Added 21.81%
171,106 $36.8 Million
Q4 2020

Feb 12, 2021
SELL
$207.01 - $276.09 $14.4 Million - $19.2 Million
-69,574 Reduced 33.12%
140,468 $33.2 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $3.35 Million - $3.97 Million
13,085 Added 6.64%
210,042 $57.2 Million
Q2 2020

Aug 11, 2020
BUY
$225.48 - $295.8 $9.18 Million - $12 Million
40,730 Added 26.07%
196,957 $57.2 Million
Q1 2020

Apr 27, 2020
BUY
$199.77 - $247.81 $3.38 Million - $4.19 Million
16,901 Added 12.13%
156,227 $37.2 Million
Q4 2019

Feb 10, 2020
BUY
$166.71 - $223.91 $176,712 - $237,344
1,060 Added 0.77%
139,326 $30.5 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $1.44 Million - $1.62 Million
8,660 Added 6.68%
138,266 $23.4 Million
Q2 2019

Aug 12, 2019
BUY
$164.61 - $190.37 $1.41 Million - $1.63 Million
8,585 Added 7.09%
129,606 $23.8 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $1.33 Million - $1.59 Million
-8,150 Reduced 6.31%
121,021 $22.3 Million
Q4 2018

Feb 13, 2019
BUY
$151.91 - $192.21 $437,652 - $553,757
2,881 Added 2.28%
129,171 $21.4 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $1.71 Million - $1.97 Million
10,203 Added 8.79%
126,290 $24.3 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $5.37 Million - $6.26 Million
36,853 Added 46.51%
116,087 $0
Q1 2018

May 10, 2018
SELL
$151.6 - $177.13 $3,183 - $3,719
-21 Reduced 0.03%
79,234 $12.9 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $395,640 - $448,295
-2,882 Reduced 3.51%
79,255 $11.9 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $12.2 Million - $13.3 Million
82,137
82,137 $12.5 Million

Others Institutions Holding VRTX

# of Institutions
1,809
Shares Held
239M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email